Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease?
作者信息
Evans Marc, Dejager Sylvie, Schweizer Anja, Foley James E
机构信息
University Hospital Llandough, Cardiff, UK,
出版信息
Diabetes Ther. 2015 Mar;6(1):1-5. doi: 10.1007/s13300-015-0104-4. Epub 2015 Mar 18.
Abstract
摘要
Zotero 插件